|
SNRNP40 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.27820000139778E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.18740000054629E-07 |
| Normal-vs-Stage2 |
7.992000E-04 |
| Normal-vs-Stage3 |
4.37480000003987E-07 |
| Normal-vs-Stage4 |
5.75730000340613E-08 |
| Stage1-vs-Stage2 |
9.035400E-01 |
| Stage1-vs-Stage3 |
6.200400E-01 |
| Stage1-vs-Stage4 |
1.119610E-01 |
| Stage2-vs-Stage3 |
8.376200E-01 |
| Stage2-vs-Stage4 |
3.003200E-01 |
| Stage3-vs-Stage4 |
2.644800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.22450000028529E-07 |
| Normal-vs-AfricanAmerican |
7.233800E-04 |
| Normal-vs-Asian |
2.35349999999634E-05 |
| Caucasian-vs-AfricanAmerican |
9.253400E-01 |
| Caucasian-vs-Asian |
6.662000E-01 |
| AfricanAmerican-vs-Asian |
8.341800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.74010000245184E-08 |
| Normal-vs-Female |
6.75010000117382E-08 |
| Male-vs-Female |
2.329400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.76860000036905E-07 |
| Normal-vs-Age(41-60Yrs) |
1.80100000024552E-07 |
| Normal-vs-Age(61-80Yrs) |
1.8428000003734E-07 |
| Normal-vs-Age(81-100Yrs) |
4.897800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.626600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.363800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.677600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.577600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.656800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.844800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.085600E-01 |
| Classical-VS-Follicular |
4.841800E-04 |
| Classical-VS-Other |
2.668400E-02 |
| Classical-VS-Normal |
4.28160000000011E-05 |
| Tall-VS-Follicular |
1.515780E-01 |
| Tall-VS-Other |
1.367370E-01 |
| Tall-VS-Normal |
4.04069999999646E-05 |
| Follicular-VS-Other |
5.553800E-01 |
| Follicular-VS-Normal |
2.22389995307992E-09 |
| Other-VS-Normal |
1.987960E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.97000000043712E-08 |
| Normal-vs-N1 |
3.70469999122491E-09 |
| N0-vs-N1 |
1.760260E-02 |
|
|
